Study to Improve Chemotherapy Side Effect Management for Adults with Gastric, Lung, Breast, or Colon Cancer Using a Digital Symptom Platform and Telenursing Support

What this Trial Is About

Researchers are assessing the clinical effectiveness and cost-efficiency of a digital health platform designed to help cancer patients manage chemotherapy side effects. This platform combines symptom reporting software called Smart Cancer Care Plus with a standardized telenursing program. The study focuses on adults diagnosed with early or advanced gastric, lung, breast, or colon cancer who are beginning their first cycle of chemotherapy with a new anticancer drug. Participants are randomly assigned to one of three groups standard care without the digital platform or telenursing, use of Smart Cancer Care Plus alone, or use of Smart Cancer Care Plus combined with standardized telenursing. The telenursing intervention includes structured telephone counseling triggered by severe symptoms or missed weekly symptom reports to ensure timely follow-up and support. Over 12 weeks, researchers will evaluate quality of life using a cancer-specific questionnaire. Additional assessments over six months will examine self-management abilities, overall health ratings, adherence to symptom reporting, chemotherapy adherence, healthcare use, functional status, symptom severity, and satisfaction with the system. Participants will be monitored regularly through digital tools and phone support to track and manage chemotherapy-related side effects throughout the study duration.

Evaluation of the Effectiveness of Managing Chemotherapy Side Effects Using ePRO and a Standardized Telenursing Program for Cancer Patients